Literature DB >> 28138741

Impurity determination for hepcidin by liquid chromatography-high resolution and ion mobility mass spectrometry for the value assignment of candidate primary calibrators.

Pauline Bros1,2,3, Ralf D Josephs4, Norbert Stoppacher2, Guillaume Cazals5, Sylvain Lehmann3, Christophe Hirtz3, Robert I Wielgosz2, Vincent Delatour1.   

Abstract

In metrology institutes, the state-of-the-art for purity analysis of peptides/proteins mainly addresses short and unfolded peptides. Important developments are anticipated for the characterization of nonlinear peptides or proteins. Hepcidin 1-25 is an interesting model system because this small protein contains four disulfide bridges with a particular connectivity that is difficult to reproduce and could induce a bias in quantification. Hepcidin 1-25 is involved in iron-related disorders and anemia, in an inflammatory context, and its clinical relevance in neurodegenerative disorders is under investigation. It is also an emerging biomarker. Recent inter-laboratory studies showed a need for standardization of hepcidin assay and the need to produce certified reference materials. This paper discusses two hepcidin standards from different synthesis pathways that have been characterized by high-resolution mass spectrometry and ion mobility mass spectrometry.

Entities:  

Keywords:  Disulfide bridges; Hepcidin; High-resolution mass spectrometry; Ion mobility, conformers; Purity assessment

Mesh:

Substances:

Year:  2017        PMID: 28138741     DOI: 10.1007/s00216-017-0202-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  2 in total

1.  In-Source Reduction of Disulfide-Bonded Peptides Monitored by Ion Mobility Mass Spectrometry.

Authors:  Bradley B Stocks; Jeremy E Melanson
Journal:  J Am Soc Mass Spectrom       Date:  2018-02-15       Impact factor: 3.109

2.  Investigations of the Copper Peptide Hepcidin-25 by LC-MS/MS and NMR.

Authors:  Ioana M Abbas; Marija Vranic; Holger Hoffmann; Ahmed H El-Khatib; María Montes-Bayón; Heiko M Möller; Michael G Weller
Journal:  Int J Mol Sci       Date:  2018-08-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.